Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Hemorrhage 13 Neoplasms 7 Leiomyoma 6 Breast Neoplasms 6 Hematologic Neoplasms 4 Thrombocytopenia 3 Postoperative Hemorrhage 3 Meningioma 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Seroma 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Myofibroma 2 Head and Neck Neoplasms 2 Colonic Neoplasms 2 Brain Neoplasms 2 Bone Neoplasms 2 Blood Loss, Surgical 2 Wrist Fractures 1 Urologic Diseases 1 Urinary Retention 1 Thromboembolism 1 Skin Neoplasms 1 Seizures 1 Sarcoma 1 Recurrence 1 Postoperative Complications 1 Polyposis, Gastric 1 Pituitary Neoplasms 1

Interventions

Levetiracetam 6 Cannabidiol 4 perampanel 2 Standard of Care 2 Everolimus 2 enzalutamide 1 Vigabatrin 1 Tranexamic Acid 1 Temozolomide 1 Sodium Chloride 1 Saline Solution 1 Pregabalin 1 Medical Marijuana 1 Magnesium Sulfate 1 Drug Therapy 1 Curcumin 1 Cholecalciferol 1 Aspirin 1 Anticonvulsants 1 Anastrozole 1 Airway Extubation 1 2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Seizures × Tranexamic Acid × Clear all

NCT04595786 2025-03-04

STAMP

Beijing Tiantan Hospital

Phase NA Completed

Meningioma, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon ⚡